MH

Mitesh Harsukhray Raval

Active Director Director DIN 08050988
DIN 08050988 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mitesh Harsukhray Raval

Data last updated:

Mitesh Harsukhray Raval is a Director at Ticos Omega Pharmaceuticals Private Limited (since 2020). The company operates in Pharma.

DIN 08050988
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Feb 20202020Active

Directorship timeline

Open interactive timeline →
Ticos Omega Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mitesh Harsukhray Raval

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitesh Harsukhray Raval

Mitesh Harsukhray Raval currently holds 1 directorship: Ticos Omega Pharmaceuticals Private Limited (Director, since 03 Feb 2020).

Mitesh Harsukhray Raval was first appointed on 03 Feb 2020 as Director at Ticos Omega Pharmaceuticals Private Limited.

The current boards of Mitesh Harsukhray Raval's companies include Hiren Harsukhray Raval (Ticos Omega Pharmaceuticals Private Limited), Jayesh Harsukhray Raval (Ticos Omega Pharmaceuticals Private Limited), Jaynesh Ratilal Patel (Ticos Omega Pharmaceuticals Private Limited), Payal Jaynesh Patel (Ticos Omega Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available